Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

Author(s):
Strehl, C.; Bijlsma, J.W.J.; Wit, M. de; Boers, M.; Caeyers, N.; Cutolo, M.; Dasgupta, B.; Dixon, W.G.; Geenen, R.; Huizinga, T.W.J. (0000-0001-7033-7520); Kent, A.; Thurah, A.L. de; Listing, J.; Mariette, X.; Ray, D.W.; Scherer, H.U. (0000-0002-5700-5617); Seror, R.; Spies, C.M.; Tarp, S.; Wiek, D.; Winthrop, K.L.; Buttgereit, F.
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2016), Vol. 75, no. 6, p. 952-957
hdl
1887/112245
doi
10.1136/annrheumdis-2015-208916